Portfolio

Hypnion

Acquired by Eli Lilly in 2007, Hypnion is a neuroscience drug discovery and development company focused on sleep disorders. The company has proprietary rights to a sleep-wake drug discovery system called SCORE-2004, which predicts human response and allows for testing of non-addictive drug candidates for sleep.

 

Back

Company Profile

Hypnion Logo
  • Founded: 2007